Utama › Kegagalan Jantung › Virginia › Arlington
Kajian klinikal Kegagalan Jantung di Arlington, VA
15 kajian untuk Kegagalan Jantung sedang mencari peserta di lokasi dalam dan sekitar Arlington (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
ELEVATE-HFpEF Clinical Study
Mengambil peserta
- Inova Fairfax Hospital, Falls Church · 4 mi jauh
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
Mengambil pesertaFasa 3
- Research Site, Falls Church · 4 mi jauh
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Mengambil pesertaFasa 3
- Carient Heart and Vascular, Manassas · 22 mi jauh
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Mengambil pesertaFasa 3
- Carient Heart and Vascular, Manassas · 22 mi jauh
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
Mengambil pesertaFasa 2
- Inova Heart and Vascular Institute, Falls Church · 4 mi jauh
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
Mengambil pesertaFasa 3
- Research Site, Arlington
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Mengambil pesertaFasa 3
- Conquest Research, LLC, Arlington
- Virginia Heart, Falls Church · 4 mi jauh
- Carient Heart and Vascular, Manassas · 22 mi jauh
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Mengambil pesertaFasa 3
- Research Site, Falls Church · 4 mi jauh
- Research Site, Burke · 11 mi jauh
- Research Site, Potomac · 11 mi jauh
- dan 2 lagi
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
Mengambil peserta
- Inova Fairfax Medical Campus, Falls Church · 4 mi jauh
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Mengambil pesertaKajian pemerhatian
- Falls Church, Falls Church · 4 mi jauh
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Mengambil pesertaFasa 3
- Conquest Research, Vienna · 9 mi jauh
- Carient Heart and Vascular, Manassas · 22 mi jauh
PRagmatic Trial Of Messaging to Providers About Treatment of Heart Failure at Inova
Mengambil peserta
- Inova Health System, Falls Church · 4 mi jauh
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
Mengambil peserta
- Inova Fairfax Medical Campus, Falls Church · 4 mi jauh
Left vs Left Randomized Clinical Trial
Mengambil peserta
- Inova Heart and Vascular Institute, Falls Church · 4 mi jauh
Cardiogenic Shock Working Group Registry
Mengambil pesertaKajian pemerhatian
- Inova Health System, Falls Church · 4 mi jauh
Kajian Kegagalan Jantung di bandar lain
- New York City, NY51 kajian
- Boston, MA44 kajian
- Dallas, TX42 kajian
- Houston, TX36 kajian
- Cleveland, OH33 kajian
- Chicago, IL31 kajian
- Philadelphia, PA31 kajian
- San Francisco, CA29 kajian
- St. Louis, MO26 kajian
- Durham, NC26 kajian
- Kansas City, MO25 kajian
- Atlanta, GA25 kajian
Kajian lain di Arlington
- Kanser Paru-paru Bukan Sel Kecil104 kajian
- Kanser Metastatik53 kajian
- Kanser Kolorektal52 kajian
- Kanser (semua jenis)48 kajian
- Kanser Payudara46 kajian
- Kanser Ovari46 kajian
- Kanser Paru-paru41 kajian
- Kanser Endometrium39 kajian
- Kanser Pankreas33 kajian
- Karsinoma Sel Skuamosa Kepala dan Leher26 kajian
- Kanser Paru-paru Sel Kecil23 kajian
- Kanser Payudara Triple-Negatif20 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.